These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hexafluorenium bromide: current status and a review. Britton RM, Figueroa M. Anesth Analg; 1973; 52(1):100-5. PubMed ID: 4567515 [No Abstract] [Full Text] [Related]
4. Characteristics of the neuromuscular block with succinylcholine and decamethonium in man. De Jong RH, Freund FG. Anesthesiology; 1967; 28(3):583-91. PubMed ID: 6023529 [No Abstract] [Full Text] [Related]
5. The effects of succinylcholine, decamethonium, hexacarbacholine, gallamine and dimethyl tubocurarine on the twitch and tonic neuromuscular systems of the cat. Katz RL, Eakins KE. J Pharmacol Exp Ther; 1966 Nov; 154(2):303-9. PubMed ID: 5922992 [No Abstract] [Full Text] [Related]
6. Plasma cholinesterase activity and neuromuscular paralysis by succinylcholine. Kelemen MH, Volle RL. Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):477-83. PubMed ID: 5916749 [No Abstract] [Full Text] [Related]
7. Activity-as a factor for the development of some pharmacological properties of the neuromuscular junction. Jones R, Vrbová G. J Physiol; 1971 Feb; 214 Suppl():17P-18P. PubMed ID: 5575355 [No Abstract] [Full Text] [Related]
8. Of magnesium, muscle relaxants, toxemic parturients, and cats. Giesecke AH, Morris RE, Dalton MD, Stephen CR. Anesth Analg; 1968 Feb; 47(6):689-95. PubMed ID: 5749331 [No Abstract] [Full Text] [Related]
9. A comparison of the effects of neuromuscular blocking agents and cholinesterase inhibitors on the tibialis anterior and superior rectus muscles of the cat. Katz RL, Eakins KE. J Pharmacol Exp Ther; 1966 May; 152(2):304-12. PubMed ID: 5944372 [No Abstract] [Full Text] [Related]
10. Neuromuscular blocking activity and other pharmacologic properties of various carnitine derivatives. Hosein EA, Booth SJ, Gasoi I, Kato G. J Pharmacol Exp Ther; 1967 Jun; 156(3):565-72. PubMed ID: 6028881 [No Abstract] [Full Text] [Related]
11. The nature of suxamethonium neuromuscular block in the dog assessed by train-of-four stimulation. Cullen LK, Jones RS. Res Vet Sci; 1980 Nov; 29(3):281-8. PubMed ID: 7255890 [Abstract] [Full Text] [Related]
12. [Calcium utilization in the neuromuscular junction after acetylcholin treatment (author's transl)]. Palánkai G, Sávay G, Poberai M. Acta Histochem; 1978 Nov; 62(2):170-5. PubMed ID: 104523 [Abstract] [Full Text] [Related]
13. In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats. Nguyen A, Ramzan I. Pharmazie; 2000 Dec; 55(12):957. PubMed ID: 11189879 [No Abstract] [Full Text] [Related]
14. The neuromuscular effects of suxamethonium in man. Katz RL, Ryan JF. Br J Anaesth; 1969 May; 41(5):381-90. PubMed ID: 5772604 [No Abstract] [Full Text] [Related]